Aquestive Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 36.5%.

Top 25 shareholders own 46.28% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
10.8%	Bratton Capital Management, L.P.	9,810,958	US$52.7m	0%	100.0%
6.1%	VR Adviser, LLC	5,555,555	US$29.8m	0%	1.07%
5.99%	BlackRock, Inc.	5,454,743	US$29.3m	306%	no data
4.64%	The Vanguard Group, Inc.	4,227,672	US$22.7m	30.4%	no data
3.13%	Franklin Resources, Inc.	2,854,242	US$15.3m	28.6%	no data
1.73%	Geode Capital Management, LLC	1,576,972	US$8.5m	193%	no data
1.52%	Daniel Barber	1,384,107	US$7.4m	0%	no data
1.25%	CHI Advisors LLC	1,140,000	US$6.1m	30.3%	1.78%
1.08%	Alexander Schobel	984,476	US$5.3m	0%	no data
1.08%	State Street Global Advisors, Inc.	984,057	US$5.3m	442%	no data
0.97%	Janney Montgomery Scott LLC, Asset Management Arm	880,485	US$4.7m	158%	0.01%
0.86%	Teachers Insurance and Annuity Association-College Retirement Equities Fund	785,023	US$4.2m	0%	no data
0.79%	Qube Research & Technologies Ltd	718,100	US$3.9m	-15.4%	0.01%
0.78%	Essex Investment Management Company, LLC	707,078	US$3.8m	0.27%	0.58%
0.7%	Keith Kendall	637,149	US$3.4m	0%	no data
0.66%	Woodline Partners LP	600,959	US$3.2m	0.06%	0.03%
0.61%	Morgan Stanley, Investment Banking and Brokerage Investments	555,986	US$3.0m	498%	no data
0.58%	Dafna Capital Management, LLC	530,000	US$2.8m	6%	0.6%
0.54%	Renaissance Technologies LLC	496,200	US$2.7m	-63.9%	no data
0.52%	Lori Braender	476,992	US$2.6m	0%	no data
0.47%	Bracebridge Capital, LLC	428,571	US$2.3m	0%	0.89%
0.44%	Stifel Asset Management Corp.	397,482	US$2.1m	1.95%	no data
0.43%	A. Toth	388,295	US$2.1m	0%	no data
0.34%	Douglas Bratton	306,476	US$1.6m	0%	no data
0.28%	Stephen Wargacki	257,963	US$1.4m	2.6%	no data